Nabil Uddin

Nabil Uddin is a seasoned biotech executive with extensive experience in business development, corporate strategy, and program management. Nabil has provided advisory services to biotech companies, focusing on corporate development and business negotiations. Previously, Nabil held the position of Vice President of Corporate Development at Concert Pharmaceuticals, where he played a pivotal role in leading the company to a successful acquisition by Sun Pharmaceuticals as well as completing several other strategic transactions.

Throughout his career, Nabil has held various roles in program management and product planning, contributing significantly to drug development projects across multiple therapeutic areas. His core competencies include expertise in transactional leadership, mergers and acquisitions, business development, and corporate strategy. Nabil has extensive experience in leading R&D teams and managing clinical development across diverse therapeutic areas. He have a proven ability to collaborate effectively across functions and with diverse audiences.

Nabil holds a Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and completed a Drug Development Fellowship at the University of North Carolina. He is a licensed pharmacist in both North Carolina and Massachusetts.